Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases

Head and Neck

Volumn 35, Issue 8, 2013, Pages 1138-1143

  Ebrahimi, Ardalan ^a   Clark, Jonathan R ^a   Ahmadi, Nazanin ^a   Palme, Carsten E ^b   Morgan, Gary J ^b   Veness, Michael J ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cutaneous squamous cell carcinoma; disease free interval; head and neck neoplasms; lymph node metastases; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; DISEASE FREE INTERVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PAROTIDECTOMY; PRIORITY JOURNAL; REGIONAL METASTASIS; RETROSPECTIVE STUDY; WIDE EXCISION;

CUTANEOUS SQUAMOUS CELL CARCINOMA; DISEASE-FREE INTERVAL; HEAD AND NECK NEOPLASMS; LYMPH NODE METASTASES; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84880696937     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23096     Document Type: Article

References (31)

1. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG,. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
2. Kwa RE, Campana K, Moy RL,. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 26: 1-26.
3. Alam M, Ratner D,. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344: 975-983.
4. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115: 1561-1567.
5. Joseph MG, Zulueta WP, Kennedy PJ,. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. Aust N Z J Surg 1992; 62: 697-701.
6. Jol JA, van Velthuysen ML, Hilgers FJ, Keus RB, Neering H, Balm AJ,. Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma. Eur J Surg Oncol 2003; 29: 81-86.
7. Veness MJ, Palme CE, Morgan GJ,. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006; 106: 2389-2396.
8. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS,. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 2001; 23: 744-748.
9. Rama N, Monteiro A, Bernardo JE, Eugénio L, Antunes MJ,. Lung metastases from colorectal cancer: surgical resection and prognostic factors. Eur J Cardiothorac Surg 2009; 35: 444-449.
10. Takakura Y, Miyata Y, Okajima M, Okada M, Ohdan H,. Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer. Colorectal Dis 2010; 12 (7 online): e68-75.
11. Onaitis MW, Petersen RP, Haney JC, et al. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg 2009; 87: 1684-1688.
12. van der Pol CC, van Geel AN, Menke-Pluymers MB, Schmitz PI, Lans TE,. Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence. Ann Surg Oncol 2009; 16: 3414-3421.
13. Chen F, Fujinaga T, Sato K, et al. Clinical features of surgical resection for pulmonary metastasis from breast cancer. Eur J Surg Oncol 2009; 35: 393-397.
14. Yhim HY, Han SW, Oh DY, et al. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. Cancer 2010; 116: 2890-2901.
15. Ueda Y, Matsumura Y, Egawa-Takata T, et al. Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma. Anticancer Res 2010; 30: 4347-4352.
16. Blackmon SH, Shah N, Roth JA, et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009; 88: 877-884; discussion 884-885.
17. Smith R, Pak Y, Kraybill W, Kane JM III,. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 2009; 35: 356-361.
18. García Franco CE, Torre W, Tamura A, et al. Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg 2010; 37: 1205-1208.
19. Shiono S, Kawamura M, Sato T, et al. Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinoma. Ann Thorac Surg 2009; 88: 856-860.
20. Shiono S, Kawamura M, Sato T, et al. Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases. J Thorac Oncol 2008; 3: 1046-1049.
21. Kemp CD, Kitano M, Kerkar S, et al. Pulmonary resection for metastatic gastric cancer. J Thorac Oncol 2010; 5: 1796-1805.
22. Pfannschmidt J, Hoffman H, Muley T, Krysa S, Trainer C, Dienemann H,. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 2002; 74: 1653-1657.
23. Cho S, Ryu KM, Hwang YJ, Lee EB,. Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma. J Thorac Oncol 2010; 5: 1251-1254.
24. Herman K, Wysocki WM, Skotnicki P, Tabor J, Luczyńska E, Komorowski AL,. Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor? World J Surg 2009; 33: 469-474.
25. Hosmer D, Lemeshow S, May S,. Applied survival analysis: regression modeling of time-to-event data. 2nd ed. New Jersey: John Wiley & Sons; 2008.
26. Forest VI, Clark JJ, Veness MJ, Milross CG,. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian cancer centers. Cancer 2010; 116: 1298-1304.
27. Veness MJ, Morgan GJ, Palme CE, Gebski V,. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005; 115: 870-875.
28. Taylor BW Jr, Brant TA, Mendenhall NP, et al. Carcinoma of the skin metastatic to parotid area lymph nodes. Head Neck 1991; 13: 427-433.
29. delCharco JO, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Mendenhall NP,. Carcinoma of the skin metastatic to the parotid area lymph nodes. Head Neck 1998; 20: 369-373.
30. Shimm DS, Wilder RB,. Radiation therapy for squamous cell carcinoma of the skin. Am J Clin Oncol 1991; 14: 383-386.
31. Ebrahimi A, Clark JR, Lorincz BB, Milross CG, Veness MJ,. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient. Head Neck 2012; 34: 365-370.